| |
From risk mitigation to program-level country and site strategy, IQVIA helped help this sponsor prove operational feasibility for six concurrent global studies. Download the case study. 
|
|
|
Wednesday, May 17, 2023 | 11am ET / 8am PT According to a recent ASHP study, 89% of pharmacists are considering Radio-frequency Identification (RFID) to tackle a variety of their operational needs. Join usto hear from both hospitals and manufacturers on the benefits of RFID and future use cases. Ensure your organization is fully equipped to meet the market's growing demand for RFID. Register now. 
|
|
| By Eric Sagonowsky,Max Bayer,Kevin Dunleavy,Zoey Becker,Fraiser Kansteiner,Andrea Park,Annalee Armstrong,Ben Adams,Gabrielle Masson,James Waldron,Nick Paul Taylor The times are changing in biopharma. We hope our selections for this year's Most Influential People in Biopharma special report reflect the trends many of our readers are seeing in the industry. |
|
|
|
By Nick Paul Taylor Innovent Biologics has strengthened its pitch for the Chinese obesity market with fresh phase 2 data. The update shows giving mazdutide, a molecule from Eli Lilly’s deep bench of obesity assets, at a higher dose dialed up the placebo-adjusted weight loss to 15.4% after 24 weeks. |
By Gabrielle Masson All the rumors are true. After months of sale speculation, Syneos Health has officially been snapped up by three private investment firm affiliates for the eye-watering sum of $7.1 billion. |
By Kevin Dunleavy Ahead of a decision from the FDA on a resubmission, Protalix and Chiesi have scored marketing approval in Europe for their challenger to Sanofi's Fabry disease therapy Fabrazyme. |
|
Wednesday, May 17, 2023 2:00pm ET / 11:00am PT Join this webinar to learn more about the opprtunity medical affairs teams and medical science liaisons (MSLs) have to engage with HCPs in clinical discussions and bridge care gaps by providing crucial insights into evidence-based medicine. Reister now to learn more. 
|
|
By Teresa Carey This week on "The Top Line," we're concluding our miniseries on Narcan the nasal spray. It is the first naloxone product to be approved for use without a prescription. |
By James Waldron Last month, Fierce Biotech told you about an unknown number of layoffs due to hit Takeda employees as the Japanese pharma moves away from early-stage R&D work in adeno-associated virus-based gene therapies and rare hematology. Now, we’ve got a better sense of the workforce impact. |
By Fraiser Kansteiner Instead of Lilly receiving the outcome it wanted, a federal judge in Illinois has tripled the amount Eli Lilly owes in damages in a long-running False Claims Act case. |
By Annalee Armstrong If at first you don’t succeed, try again. That’s what NGM Biopharma has done with a previously failed nonalcoholic steatohepatitis candidate, in hopes that it could provide some light at the end of a dark time in the clinic. |
By Andrea Park As Twist Bioscience aims to untangle its operations and focus only on its most potentially profitable work, the synthetic DNA maker is cutting down its workforce. |
By Fraiser Kansteiner Starting at the end of May, BMS will roll out job cuts for 48 employees in Princeton, New Jersey, according to a new Worker Adjustment and Retraining Notification alert filed with the state. The BMS site in question is a 650,000-square-foot facility that houses employees from the commercial team, plus commercialization and late-stage development partners from the R&D unit. |
By Fraiser Kansteiner After an April communique warning of reduced sales and productivity issues at three- plants, Catalent delayed the release of its earnings for the third fiscal quarter. The report was originally scheduled to roll out Tuesday. Catalent said in a release Monday it’s now angling to unveil its quarterly report on May 15. |
By Kevin Dunleavy Pfizer and AstraZeneca have retained their crowns as the most transformative companies in the industry, according to IDEA Pharma. On IDEA’s annual Innovation and Invention Index, Pfizer and AZ held the top spots for the second straight year. |
By Helen Floersh A new universal receptor system designed by a research team from the University of Pittsburgh could make engineering custom T-cell therapies far more efficient. |
Fierce podcasts Don't miss an episode |
| This week on "The Top Line," we're concluding our miniseries on Narcan the nasal spray. It is the first naloxone product to be approved for use without a prescription. |
|
|---|
|
|
|
Tuesday, May 23, 2023 | 2pm ET / 11am PT Clinical trials are complex, time-consuming, and costly. But what if you could use simulation to guide your decisions and optimize your trial design? In this webinar, we'll discuss the power of simulation-guided trial design (SGTD) and explain its benefits to clinical development strategies. Register now to join us. 
|
|
Whitepaper ChatGPT shows promise in drug discovery for information extraction, scientific text authoring, hypothesis prediction, and chemical entity prediction. This whitepaper explores its potential to streamline research, delving into its technology, applications, and limitations. Sponsored by: Elucidata Corp., Cloud SAAS in Life Sciences R&D |
Whitepaper Learn how a GPCR-focused library with a cell-based biopanning strategy led to the discovery of 13 high-affinity and selective anti-GLP-1R antibodies with highly developable therapeutic properties. Sponsored by: Twist Bioscience |
Whitepaper Discover the new gold standard for gene therapy protein expression potency measurements. Sponsored by: Bio-Techne |
eBook Discover a game-changing approach to clinical research with Hybrid and Decentralized Clinical Trials (DCTs). Learn about the benefits, challenges, and key elements for success. Sponsored by: EvidentIQ |
Research What role do the Library and Legal teams play in the drug development pipeline at Lilly? An import one – find out how. Sponsored by: CCC |
Whitepaper This paper focuses on stakeholder engagement and how Medical Affairs teams’ responsibilities, goals, tools, and techniques are changing. Sponsored by: Blue Matter, strategic consultants in the life sciences |
Research Strategies for Optimal Site Selection and Feasibility Research in Novel Therapies and Geographies Sponsored by: H1 |
Whitepaper How can eConsent provide a more flexible approach to informed consent? Sponsored by: YPrime |
Whitepaper Preparation of critical process liquids and buffer components shifts resources away from core activities and can be filled with inefficiencies and risks that can increase time and costs across your workflow. Learn about the framework to help reduce your total costs beyond capital and operational expenditures and set a solid foundation for successful scale-up of buffer preparation. Sponsored by: Thermo Scientific Production Chemicals and Services |
Whitepaper Learn how Catalent’s extensive network across APAC can meet a wide range of clinical supply needs for sponsors conducting trials within the region. Sponsored by: Catalent |
Whitepaper Explore Catalent’s newest clinical supply facility in Japan, including the comprehensive services & solutions it offers to help support trials both in-country & around the world. Sponsored by: Catalent |
| July 18-19, 2023 | Jersey City, NJ |
|
|
| |
|
